Meet our Speakers:
Dimitris Agrafiotis , PhD, FRSC, is Vice President of Pfizer Digital, where he is responsible for leading the digital strategy and portfolio for Pfizer’s Worldwide Research, Development and Medical organization. Dr. Agrafiotis received his PhD in theoretical chemistry from Imperial College London in 1988, and held postdoctoral fellowships at the University of California, Berkeley and Harvard, where he worked with Nobel laureate EJ Corey. Before joining Pfizer, he worked at Parke-Davis, 3-Dimensional Pharmaceutical, Johnson & Johnson, Covance, and most recently Novartis as Chief Information Officer of its research division. Dr. Agrafiotis’ work is documented in more than 100 peer-reviewed publications and book chapters and 18 issued US patents. In 2012 he was elected Fellow of the Royal Society of Chemistry for his contributions to chemical and pharmaceutical research, and in 2016 he was named in Computerworld’s Premier 100 Technology Leaders for his technology leadership and innovative approaches to business challenges.
Kevin R. Haas, chief technology officer, joined Myriad in May 2013. Previously, he was vice president of Bioinformatics. Dr. Haas also serves on the Board of Directors and is vice president for USA Triathlon, the non-profit national governing body for the sport. Dr. Haas received a B.S. from University of Wisconsin-Madison and a Ph.D. in Chemical Engineering from University of California-Berkeley, where he worked on molecular simulation and machine learning to study protein dynamics from single molecule fluoresce. He has co-authored 16 peer reviewed publications and eight patent applications.
Sol Rashidi is currently the Chief Analytics Officer at Estée Lauder Companies Inc. and previously served as the Chief Data & Analytics Officer at Merck. Prior to joining Merck, Sol was Chief Data Officer for Sony Music; Chief Data & AI Officer for Royal Caribbean; and AI, Data & Analytics Partner at Ernst & Young. Sol helped launch IBM’s “Watson” into the marketplace, pioneering some of IBM’s latest advances in Enterprise Information Management. Sol has 7 patents issued and 21 filed. She has received numerous awards and recognitions, including “50 Most Powerful Women in Tech,” “#4 in Top 20 CDOs,” “Top 100 Innovators in Data & Analytics,” and “2020 list of Global Data Power Women.” Sol focuses on creating a community amongst technologist and non-technologists to help businesses push past their capabilities, establish stronger positioning in the marketplace, and make a difference when using the latest advancements in Technology, Data Science, Automation, Engineering, Product Development, Data Visualization, AI, Multi-Cloud Infrastructure and Marketing Analytics.
Prof. Teresa Head-Gordon received her BS in Chemistry from Case Western Reserve University in 1983 and her Ph.D. in Theoretical Chemistry from Carnegie Mellon University in 1989. She currently is Chancellor’s Professor in the Departments of Chemistry, Bioengineering, and Chemical and Biomolecular Engineering at the University of California, Berkeley. She has been a recipient of an IBM SUR award in 2001 and was a Schlumberger Fellow at Cambridge University, UK (2005-2006) and is a Fellow of the American Chemical Society, American Institute for Medical and Biological Engineering, and RESOLV German Center of Excellence. She serves as co-Director of CalSolv and the national Molecular Sciences and Software Institute. She serves/served as Editorial Advisory Board Member for the Journal of Chemical Physics (2017-2020); Journal of Computational Chemistry (2003-), Journal of Physical Chemistry (2009-2011); Molecular Physics (2018-); Theoretical Chemistry Accounts (2010-2013); and SIAM book series on Computational Science and Engineering (2004-2008), as well as an editor for Biophysical Journal (2003-2006).